Summary

According to the latest Global Burden of Diseases Report, 2017, India has one of the highest-burden of chronic respiratory diseases. India contributes to 15.69% of Global Chronic Respiratory Diseases but 30.28% of all global deaths due to Chronic Respiratory Disease occur in India. India has the highest number of COPD (Chronic Obstructive Pulmonary Disease) cases in the world, a whopping 55.23 Million. The second-largest number of global deaths due to COPD, almost 0.85 million, occur in India. India also leads the world in deaths due to Asthma with 43% of global asthma deaths occurring in our country. Yet awareness in the healthcare community and the public remains low about these two chronic lung conditions which cause a huge health and economic burden on our health and health care system. The Chest Research Foundation (CRF) was established by Cipla Ltd. as a Public Charitable Trust to address the unmet needs of research and knowledge dissemination in the field of Obstructive Airways Diseases in India. In India, an integrated surveillance of Influenza like Illness (ILI) and Severe Acute Respiratory Illness (SARI) for the detection of the human influenza virus and SARS-COV-2 virus is ongoing through structured ILI/SARI surveillance network of 28 sites. The surveillance network is comprised of 27 DHR-ICMR’s Virus Research & Diagnostic Laboratories and the country’s National Influenza Centre (WHO-NIC) housed at ICMR-National Institute of Virology Pune, also a WHO Collaborating Centre for Global Influenza Surveillance & Response System (GISRS).

According to the research report "India Respiratory Care Devices Market Overview, 2028," published by Bonafide Research, the market is anticipated to add more than 10 Million from 2023 to 2028. Several factors that emphasize the rising importance of respiratory health in the nation are driving the market for respiratory care devices in India, which is expanding at an impressive rate. This growth is a sign of how common respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea are becoming. These conditions are frequently brought on by toxins in the environment, high smoking rates, and alterations in lifestyle. The demand for cutting-edge respiratory care solutions is increased because of India's expanding population, especially its elderly population. The need for respiratory support has been further highlighted by the COVID-19 epidemic, which has resulted in a spike in demand for ventilators and oxygen concentrators. India's improving healthcare infrastructure, characterized by a network of hospitals, clinics, and specialty respiratory care centers, has been instrumental in the adoption of advanced respiratory care devices. Furthermore, government initiatives to strengthen the healthcare system and enhance public health awareness campaigns are driving investment in respiratory care. The country's commitment to reducing tobacco use and mitigating pollution is creating a conducive environment for respiratory health. Additionally, as technological advancements continue to make respiratory care devices more efficient, user-friendly, and accessible, the market is poised for even more robust growth. The confluence of these factors underscores the importance of respiratory health in India and the growing need for innovative, reliable, and accessible respiratory care devices.

In the intricate segmentation of India's respiratory equipment market, product types encompass therapeutic devices, monitoring devices, diagnostic devices, and consumables and accessories. Therapeutic devices emerge as the primary force dominating the market, reflecting the high demand for devices essential in managing respiratory conditions prevalent in the country. This category includes nebulizers, inhalers, and positive airway pressure machines, all crucial in providing relief and improving the quality of life for individuals dealing with chronic respiratory illnesses like asthma and chronic obstructive pulmonary disease (COPD). Alongside therapeutic devices, monitoring and diagnostics devices also assert a significant market share. These tools, such as pulse oximeters, spirometers, and sleep apnea diagnostic equipment, play a vital role in tracking patient health indicators, aiding in disease management and diagnosis. The growing emphasis on preventive healthcare and early disease detection has propelled the adoption of advanced monitoring and diagnostic technologies, thus reinforcing the significant presence of these segments in India's respiratory equipment market.

Within the landscape of disease indications in India's respiratory equipment market, chronic obstructive pulmonary disease (COPD) asserts a notable dominance. This chronic and progressive lung condition presents a significant healthcare burden in the country, spurring a substantial demand for respiratory devices specifically tailored for COPD management. Devices such as inhalers, nebulizers, and oxygen therapy solutions play a critical role in providing relief and therapeutic intervention for individuals coping with COPD. The high prevalence of COPD in India has fortified the prominence of this disease indication, propelling a comprehensive market for devices aimed at easing symptoms, improving lung function, and enhancing the quality of life for affected individuals. Following closely behind, asthma stands as another key player in the market. With its widespread occurrence and the need for inhalers, nebulizers, and preventive management strategies, asthma contributes significantly to the demand for respiratory devices. The prevalence of both COPD and asthma underlines the critical role of respiratory equipment in addressing these prevalent chronic conditions, highlighting the pivotal position of these diseases within India's respiratory equipment market. Sleep apnea and infectious diseases emerge as influential factors shaping the demand for specialized devices. Sleep apnea, characterized by disruptions in breathing during sleep, occupies a significant portion of the market share owing to increased recognition and diagnosis. This condition necessitates advanced respiratory devices like continuous positive airway pressure (CPAP) machines and bilevel positive airway pressure (BiPAP) machines that assist in maintaining open airways, thus providing effective therapy for sleep-disordered breathing.

In the dynamic landscape of India's respiratory equipment market, the segmentation based on end-users showcases hospitals as the primary players, serving as crucial hubs for respiratory care. With their advanced infrastructure, specialized medical personnel, and comprehensive resources, hospitals play an integral role in providing immediate and extensive care for individuals with severe respiratory conditions. These institutions cater to acute cases, offering a wide array of respiratory devices, including ventilators, oxygen concentrators, and advanced monitoring tools, ensuring efficient management and treatment of respiratory ailments. However, an evolving trend indicates the rising significance of home care settings within the market. Over recent years, there has been a notable transition towards home care solutions as an emerging and increasingly influential end user. This shift is propelled by several factors, including the growing emphasis on patient-centric care, technological advancements facilitating portable and user-friendly respiratory devices, and the preference for receiving medical treatment in the comfort of one's home. With the prevalence of chronic respiratory conditions such as COPD and sleep apnea, the market is witnessing a surge in demand for home care solutions. This trend anticipates that home care settings will progressively secure a more significant market share, providing patients with effective respiratory equipment to be used at home. The rise of home care settings not only offers greater comfort and convenience for patients but also potentially reduces the strain on hospital resources and healthcare costs, contributing to a more holistic and patient-oriented approach in India's respiratory care landscape.

Considered in this report:
• Geography: India
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• India Respiratory Care Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type:
• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents